Published in Eur J Neurol on January 07, 2010
Survey of medication usage patterns among essential tremor patients: movement disorder specialists vs. general neurologists. Parkinsonism Relat Disord (2010) 1.07
Treatment of Essential Tremor: Are there Issues We are Overlooking? Front Neurol (2012) 0.93
Octanoic acid in alcohol-responsive essential tremor: a randomized controlled study. Neurology (2013) 0.86
Pharmacotherapy of essential tremor. J Cent Nerv Syst Dis (2013) 0.81
Essential tremor with ubiquitinated intranuclear inclusions and cerebellar degeneration. Clin Neuropathol (2012) 0.79
Medical treatment of essential tremor. J Cent Nerv Syst Dis (2014) 0.78
Defining the Treatment Gap: What Essential Tremor Patients Want That They Are Not Getting. Tremor Other Hyperkinet Mov (N Y) (2015) 0.77
Medication non-adherence in essential tremor. Parkinsonism Relat Disord (2014) 0.76
Movement disorders: New hope for medically-refractory essential tremor? Nat Rev Neurol (2016) 0.75
Effect of Primidone on Dentate Nucleus γ-Aminobutyric Acid Concentration in Patients With Essential Tremor. Clin Neuropharmacol (2016) 0.75
Sustained Medication Reduction Following Unilateral VIM Thalamic Stimulation for Essential Tremor. Tremor Other Hyperkinet Mov (N Y) (2012) 0.75
Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2005) 2.16
Reasons for adherence with antihypertensive medication. Int J Cardiol (2001) 2.15
Discontinuation of statin therapy and clinical outcome after ischemic stroke. Stroke (2007) 2.07
Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance. Clin Ther (2005) 1.84
Jaw tremor: prevalence and clinical correlates in three essential tremor case samples. Mov Disord (2006) 1.63
Relationships between beliefs about medications and adherence. Am J Health Syst Pharm (2009) 1.39
Essential tremor-the most common movement disorder in older people. Age Ageing (2006) 1.13
Preferences and practices of Americans and their physicians in antihypertensive therapy. Am J Med (1986) 0.99
Involvement of dihydropyridine receptors in excitation-contraction coupling in skeletal muscle. Nature (1987) 6.29
Measurement and modification of free calcium transients in frog skeletal muscle fibres by a metallochromic indicator dye. J Physiol (1983) 4.69
Time course of calcium release and removal in skeletal muscle fibers. Biophys J (1984) 3.92
A general procedure for determining the rate of calcium release from the sarcoplasmic reticulum in skeletal muscle fibers. Biophys J (1987) 3.67
Roles of a membrane-localized beta subunit in the formation and targeting of functional L-type Ca2+ channels. J Biol Chem (1995) 2.19
Nonlinear charge movement in mammalian cardiac ventricular cells. Components from Na and Ca channel gating. J Gen Physiol (1989) 2.02
Intramembrane charge movement in frog skeletal muscle fibres. Properties of charge 2. J Physiol (1987) 1.94
Regulation of skeletal muscle Ca2+ release channel (ryanodine receptor) by Ca2+ and monovalent cations and anions. J Biol Chem (1997) 1.76
Identification of palmitoylation sites within the L-type calcium channel beta2a subunit and effects on channel function. J Biol Chem (1996) 1.73
Faster rate of cognitive decline in essential tremor cases than controls: a prospective study. Eur J Neurol (2010) 1.68
Ca2+ sparks and embers of mammalian muscle. Properties of the sources. J Gen Physiol (2003) 1.45
Simultaneous measurements of Ca2+ currents and intracellular Ca2+ concentrations in single skeletal muscle fibers of the frog. Can J Physiol Pharmacol (1987) 1.29
Cell type specific trans-acting factors are involved in alternative splicing of human fibronectin pre-mRNA. EMBO J (1989) 1.27
Use of a metallochromic indicator to study intracellular calcium movements in skeletal muscle. Cell Calcium (1985) 1.26
The absorption of iron as supplements in infant cereal and infant formulas. Pediatrics (1975) 1.21
Relationship of maternal and infant iron stores as assessed by determination of plasma ferritin. Pediatrics (1975) 1.11
Iron metabolism and iron deficiency in infancy and childhood. Adv Pediatr (1974) 1.06
Sequence analysis and in vivo expression show that alternative splicing of ED-B and ED-A regions of the human fibronectin gene are independent events. Nucleic Acids Res (1988) 0.92
Risk-based fluconazole prophylaxis of Candida bloodstream infection in a medical intensive care unit. Eur J Clin Microbiol Infect Dis (2008) 0.90
Intravascular lymphoma: magnetic resonance imaging correlates of disease dynamics within the central nervous system. J Neurol Neurosurg Psychiatry (2005) 0.90
Apoptosis in substantia nigra following developmental hypoxic-ischemic injury. Neuroscience (1995) 0.90
Expression of c-fos, c-jun, and c-jun N-terminal kinase (JNK) in a developmental model of induced apoptotic death in neurons of the substantia nigra. J Neurochem (1999) 0.87
Neuron death in the substantia nigra of weaver mouse occurs late in development and is not apoptotic. J Neurosci (1996) 0.83
Subclinical tremor in normal controls with versus without a family history of essential tremor: data from the United States and Turkey. Eur J Neurol (2009) 0.78
Early diagnosis of leukoencephalopathy of acute lymphocytic leukemia by MRI. Pediatr Neurol (1992) 0.76
Stereotactic hypothalamotomy for behaviour disorders. J Neurol Neurosurg Psychiatry (1972) 0.75
[Thalasemia in Chile (author's transl)]. Rev Med Chil (1975) 0.75
[Quick detection of alpha-fetoprotein by crossed electrophoresis (author's transl)]. Rev Med Chil (1975) 0.75
Herpes and cytomegalovirus esophagitis. Endoscopy (2012) 0.75
Meckel's ileitis versus Crohn's ileitis: diagnosis using balloon enteroscopy. Endoscopy (2012) 0.75
[A test of parathyroid functional reserve]. Rev Med Chil (1965) 0.75
Differences between patients with non-Hodgkin's lymphomas in a cohort of HIV/AIDS patients in Puerto Rico. Cell Mol Biol (Noisy-le-grand) (2003) 0.75
Definitive radiation therapy for treatment of laryngeal carcinoma: impact of local relapse on outcome and implications for treatment strategies. Strahlenther Onkol (2013) 0.75
Vertebral osteoporotic fractures with height loss secondary to Cushing's disease. Acta Reumatol Port (2015) 0.75
[Stereotaxic hypothalamolysis]. Prensa Med Argent (1971) 0.75
The inotropic memory of amphibian myocardium. Arch Int Physiol Biochim (1977) 0.75
[Effects of diets of different protein and isonitrogenous composition, on the arterial ammonia of patients with cirrhosis]. Rev Med Chil (1967) 0.75
Recurrent pneumonia mortality risk in a HIV/AIDS Puerto Rican cohort. Cell Mol Biol (Noisy-le-grand) (2003) 0.75
The inotropic memory of amphibian myocardium. I.-Identification of two stimultaneous mechanisms and statement of a model. Arch Int Physiol Biochim (1975) 0.75
[Histochemical reactions of odontogenesis in the white rat]. An Fac Odontol (1977) 0.75
[Quick detection of alpha-fetoprotein by crossed electrophoresis (author's transl)]. Rev Med Chil (1975) 0.75
Black esophagus. Dis Esophagus (2011) 0.75
[2 cases of aplastic anemia treated with oxymetholone]. Rev Chil Pediatr (1970) 0.75
Gastrointestinal: anal Buschke Loewenstein tumor. J Gastroenterol Hepatol (2012) 0.75